Search

everythinglearnresearchcommunity

for

Search:↓

Some skin diseases and their treatments can negatively affect male fertility.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

The chapter explains that there are many genetic skin disorders affecting skin cell formation, including both common and rare types.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Thyroid hormone may be useful for treating various skin conditions and needs more research.

Muscles can make their own androgens, which may help muscle growth.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.